您的当前位置:首页 > 行业数据 > EVM14是一款靶向5种肿瘤相关抗原(TAA)的疫苗
图片属性
图片格式:PNG 图片大小:511KB 图片尺寸:1671*850
同报告图片
 / 4
EVM14是一款靶向5种肿瘤相关抗原(TAA)的疫苗_第1页
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
EVM14是一款靶向5种肿瘤相关抗原(TAA)的疫苗_第2页
fCBDS0TliIbmnJ8gfCBlR0ZSIFttbMK3bWlu4oG7wrnCtygxLjczIG3CsinigbvCuV0gfCDmj4/ov7AgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgRzEgfCDiiaU5MCB8IOato+W4uOaIluWinumrmCB8CnwgRzIgfCA2MH44OSB8IOi9u+W6puS4i+mZjSB8CnwgRzNhIHwgNDV+NTkgfCDovbvoh7PkuK3luqbkuIvpmY0gfAp8IEczYiB8IDMwfjQ0IHwg5Lit6Iez6YeN5bqm5LiL6ZmNIHwKfCBHNCB8IDE1fjI5IHwg6YeN5bqm5LiL6ZmNIHwKfCBHNSB8IDwxNSB8IOiCvuihsOerrSB8
EVM14是一款靶向5种肿瘤相关抗原(TAA)的疫苗_第3页
EVM14是一款靶向5种肿瘤相关抗原(TAA)的疫苗_第4页
fCAyMDIzIHwgMjAyNCB8CnwtLS0tLS0tLXwtLS0tLS0tLXwKfCAyMS4wICAgfCAzNTMuNCAgfAp8IDk5LjAgICB8IDM1Mi44ICB8
EVM14是一款靶向5种肿瘤相关抗原(TAA)的疫苗_第5页
所属报告: 云顶新耀-港股公司深度报告:肾科大单品进入医保放量多领域创新药进入收获期-250518(31页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠